Menu UF Health Home Menu
 

In the News

We invite you to learn more about the innovative research and patient care efforts taking place at the UF Diabetes Institute. Together, our many important contributions to the field help strengthen our organizational mission and improve the health outlook for all who are impacted by this disease.

Cusi 150x150

Dr. Kenneth Cusi Wins 2015 College of Medicine Clinical Research Award

Congrats to Dr. Cusi! The 2015 recipient of the UF College of Medicine Faculty Research Award in Clinical Science. Dr. Cusi is the principal investigator of a number of ongoing clinical research projects. His grants focus on cutting-edge research in adult endocrinology, diabetes and metabolism, both on clinical and basic research aspects related to the role of obesity and lipotoxicity in the development of Type 2 diabetes and its complications. Read more.

Nike-Running-and-Sunrise-HD-Wallpaper

Even small amounts of physical activity benefit longetivity

Todd M. Manini, associate professor in the Department of Aging and Geriatric Research, was quoted in a recent Reuters article about slight physical activity leading to substantial health benefits. The story also ran In Fox News, Yahoo! Finance and The Huffington Post. Read more.

DeHoff

UF Health pharmacist wins cardiology award

Affiliate diabetes researcher Rhonda Cooper-DeHoff, UF College of Pharmacy, has received the American College of Cardiology’s 2015 Distinguished Associate Award. Dr. Cooper-DeHoff’s research emphasizes achieving healthy blood pressure control through reduction of risk factors for hypertension and type 2 diabetes. Read more.

AnastasiaAO

UF Jonas Scholar Aluma presents at Annual Nursing Conference

Anastasia Albanese-O’Neil, PhD, ARNP, CDE, assistant professor in the UF College of Nursing, was recently highlighted by the Jonas Center for Nursing Excellence for her research on mobile diabetes technology presented at the Southern Nursing Research Society annual conference, entitled Fathers, Diabetes Education, and Mobile Technology. Read more.

Concannon-(2)

Genetics breakthrough will boost diabetes research

UF genetics expert Patrick Concannon, Ph.D., is part of group that has homed in on the genes suspected in Type 1 diabetes. “It’s a game-changer,” he said.

Haller-Michael_2907_Kiewel

Combination therapy for diabetes

Results from a UF Health pilot study have led to a new national trial investigating a combination treatment for individuals newly diagnosed with Type 1 diabetes.

Mathews Bio

New American Diabetes Association Grants Expand Diabetes Research

University of Florida researchers have received two new multi-year grants totaling nearly $900,000 in funding from the American Diabetes Association; enabling the launch of new scientific studies in Type 1 diabetes and diabetes-linked eye disease. Both awards seek to identify new therapies for early intervention and provide a foundation for future research. Read more.

blue_medicine_525

Diabetes drug shows early promise as treatment for lupus

A new treatment that may reverse the effects of the most common type of lupus has shown promising results after undergoing early testing by a team of researchers at UF Health.

Atkinson Director

UF Diabetes Institute 2014 Year in Review

Read about the UF Diabetes Institute's 2014 accomplishments as highlighted in the January column of “On the Same Page” by David S. Guzick, M.D., Ph.D., UF senior vice president for health affairs and president of UF Health. Read more.

Atkinson-to-use

UF Diabetes Institute Director, Researcher Honored by JDRF

Mark A. Atkinson, PhD., director of the University of Florida Diabetes Institute, and Alberto Pugliese, M.D., head of the Immunogenetics Program at the University of Miami's Diabetes Research Institute, were recently honored with the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award on behalf of the JDRF Network for Pancreatic Organ Donors with Diabetes (nPOD). Learn more.

The JDRF Network for Pancreatic Organ Donors with Diabetes project provides pancreatic tissue samples to more than 140 research projects across 17 countries.

University of Florida and U. Miami to bolster Type 1 diabetes research collaboration

Researchers at the University of Florida Diabetes Institute and University of Miami Diabetes Research Institute will share a new $3.3 million collaborative grant awarded by The Leona M. and Harry B. Helmsley Charitable Trust that will help fast-track significant discoveries in Type 1 diabetes worldwide. Read more.

Cusi

Researchers unravel complicated relationship between diabetes and HCV

Kenneth Cusi, M.D., F.A.C.P., F.A.C.E., Chief of Division of Adult Endocrinology, Diabetes, and Metabolism at the University of Florida, is featured in the January print issue of Endocrine Today for research related to the underlying links between diabetes and liver disease. The cover story focuses on the complicated relationship between diabetes and hepatitis C virus. Read more.

Walgreens

UF T1D research among JDRF’s Top 10 Research Advances in 2014

A collaborative type 1 diabetes study led by researchers from UF and the Institute of Diabetes Research, Helmholtz Zentrum Munchen, in Germany is recognized among JDRF's Top 10 Research Advances in 2014. The JDRF-funded research has shed more light on the connection between T1D, gut bacteria interactions, and certain viruses. Learn more.

Schatz-slider

American Diabetes Association Announces 2015 Board of Directors

UF Health Type 1 diabetes expert Desmond Schatz, M.D. has been elected to the American Diabetes Association's Board of Directors for 2015. Dr. Schatz has been a volunteer for the ADA for more than 25 years and has served on numerous committees. Dr. Schatz previously served on the national Board of Directors and was recently named president-elect of the American Diabetes Association, the nation's largest and leading voluntary health organization leading the fight to Stop Diabetes®, beginning in 2016.

ben

$1.5 million grant targets immune cell therapies in Type 1 diabetes

Benjamin Keselowsky, Ph.D. has received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.

10349024_10154601931370223_8075969735757554008_n

JDRF Bag of Hope program launches at UF Health Shands Children’s Hospital

UF Health Shands Children’s Hospital and JDRF are partnering to help newly diagnosed patients and families of young children with Type 1 diabetes. The JDRF Bag of Hope is filled with useful resources for both the child who has been diagnosed with T1D and his or her adult caregivers. Learn more.

stabler-news

Nationally-recognized T1D biomedical engineer joins UF Diabetes Institute

Cherie Stabler, Ph.D., of the University of Florida College of Engineering, together with her team, were recently awarded a $4.9 million grant to engineer a microchip that will serve to house islets that produce beta cells. Her team hopes to use the microchips to improve the current amount of islets available to transplant into patients with diabetes, as well as screen pharmaceuticals and create beta cells from stem cells.

otsp-placeholder

On the Same Page: The UF Diabetes Institute

In the latest issue of On the Same Page, UF Health president David S. Guzick, M.D. Ph.D. details the events leading up to the formation of the new UF Diabetes Institute — a collaboration of dozens of researchers campuswide all focused on forging new advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians.

PicMonkey Collage

The University of Florida Diabetes Institute

The University of Florida has formed a new institute dedicated to diabetes research, patient care, and innovation. Learn about the latest system-wide effort toward a collaborative approach toward the research and treatment of this disease.

Do-I-Qualify

ADA position statement addresses diabetes in child care setting

Type 1 diabetes care for children aged 5 years or younger requires unique management, according to a recent position statement in Diabetes Care. Authors stress that pediatric diabetes patients need a proactive disease care plan that involves clinicians, parents/guardians and child care staff. Researchers also highlighted hurdles in pediatric diabetes care, including language barriers, health literacy and ethnic and cultural practices.


News Archive

2015
2014
2013

2012
2011
2010
2000’s